Printer Friendly
The Free Library
14,504,174 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Mobile Training Unit Demonstrates New Boston Scientific Embolic Protection System; Provides Physicians with Cutting-Edge Medical Training Opportunity.


Business Editors/Health/Medical Writers

NATICK, Mass.--(BUSINESS WIRE)--June 12, 2003

Boston Scientific The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions,  Corporation (NYSE NYSE

See: New York Stock Exchange
: BSX BSX Bermuda Stock Exchange
BSX Bandai Satellaview-X
BSX Bicycle Super-X (Cross) 
) today announced that it is featuring a mobile, state-of-the-art simulated cardiac catherization lab at Mt. Sinai Hospital in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
 in which physicians can get hands-on experience with a new embolic embolic /em·bol·ic/ (em-bol´ik) pertaining to an embolus or to embolism.

em·bol·ic
adj.
1. Relating to, or caused by an embolus or embolism.

2. Relating to emboly.
 protection system.

Physicians will be training on the new FilterWire EX(TM) Embolic Protection System. The FilterWire EX Embolic Protection System, recently cleared by the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
, is designed to reduce health risks during angioplasty and vascular interventions by capturing embolic material dislodged during those procedures. The debris captured by the filter could otherwise travel through and block the coronary arteries Coronary arteries
The two main arteries that provide blood to the heart. The coronary arteries surround the heart like a crown, coming out of the aorta, arching down over the top of the heart, and dividing into two branches.
 where it could potentially cause a heart attack. The filter is removed after the procedure.

"Interventional cardiologists now have the opportunity to learn how to use a potent new tool in a computer-simulated environment rather than in a real-patient environment," said Donald Baim, MD, director of the Center for Integration of Medicine and Innovative Technology. He continued, "By offering this unique training with the SimSuite(R) Education System, Boston Scientific provides the healthcare community with the training needed to provide the highest standard of healthcare."

The mobile unit will be at Mt. Sinai Hospital tomorrow (June 13) from 9:00 a.m. to 3:00 p.m. and media tours are available. Please call Meaghan Shields at 617-529-6357 to arrange for an interview and demonstration.

About Boston Scientific

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

SimSuite is a registered trademark of Medical Simulation Corporation.

This press release contains forward-looking statements. The Company wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with the commercialization of new technologies, competitive offerings, intellectual property and other factors described in the Company's filings with the Securities and Exchange Commission.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 12, 2003
Words:342
Previous Article:Court Affirms $10 Million Judgment for Sheppard Mullin Client.
Next Article:NOVA Chemicals Reports No Injuries or Environmental Impact from its Bayport, Texas Facility Fire.
Topics:



Related Articles
EDUCATIONAL DESIGN.
FIREFIGHTERS PRACTICE FOR CHEMICAL ATTACK.(News)
Rubicon Medical Receives $2 Million Strategic Investment From Boston Scientific.
Rubicon Medical Receives $15 Million from Boston Scientific as Parties Enter Definitive Agreements; Boston Scientific Now Owns 18 Percent of Rubicon...
Boston Scientific and Body1 Launch Online Resource for Women Suffering from Uterine Fibroids.
Guidant Receives First U.S. Approval for New Therapy Designed to Reduce Risk of Stroke; New Carotid Stent System Offers Minimally Invasive...
Meet the new AMAA president.(Biography)
Sports medicine: the primary care perspective.(Featured CME Topic: Sports Medicine)
A vision for the future.(DIRECTOR'S PERSPECTIVE)
Guidant Announces Positive Preliminary Results of Large Real-World Carotid Artery Stenting Study; Study Suggests Therapy Can Be Performed Safely by...

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles